AstraZeneca vaccine's chief investigator backs Covishield dose gap

Backing the 12-16 weeks gap between the two doses of Covishield in the country, the chief investigator of the AstraZeneca vaccine clinical trials on Friday said that the level of protection......

'I expect a third wave by December'

'We must not forget that the virus will continue to adapt itself to live with us.''The vaccine is the only one way we can prevent mortality.' IMAGE: COVID-19 vaccination at K R market in......

Oxford jabs effective against severe Covid: US trial

A large trial in the United States and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at preventing symptomatic COVID-19 and 100 per cent......

Oxford launches COVID-19 vaccine study on children

The University of Oxford has launched the first study to assess the safety and immune responses in children and young adults of its coronavirus vaccine. The university said that previous trials of......